Surgery Partners Inc. (NASDAQ:SGRY)’s share price dropped 0.3% on Friday . The company traded as low as $17.16 and last traded at $17.84, with a volume of 84,398 shares traded. The stock had previously closed at $17.89.

SGRY has been the topic of a number of research reports. KeyCorp initiated coverage on shares of Surgery Partners in a research note on Thursday, June 9th. They issued an “overweight” rating and a $21.00 price target on the stock. Goldman Sachs Group Inc. dropped their price target on shares of Surgery Partners from $23.00 to $20.00 in a research note on Monday, March 14th. Zacks Investment Research downgraded shares of Surgery Partners from a “hold” rating to a “sell” rating in a research note on Wednesday, April 6th. Royal Bank Of Canada dropped their price target on shares of Surgery Partners from $22.00 to $20.00 and set an “outperform” rating on the stock in a research note on Monday, March 14th. Finally, Citigroup Inc. dropped their price target on shares of Surgery Partners from $25.00 to $21.00 and set a “buy” rating on the stock in a research note on Monday, March 14th. Three analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $22.75.

The stock’s 50-day moving average is $15.53 and its 200 day moving average is $15.56. The firm has a market capitalization of $868.10 million and a PE ratio of 716.00.

Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings data on Thursday, May 5th. The company reported ($0.15) EPS for the quarter, missing analysts’ consensus estimates of $0.03 by $0.18. The firm had revenue of $267.10 million for the quarter, compared to the consensus estimate of $255.06 million. Surgery Partners’s revenue for the quarter was up 19.2% compared to the same quarter last year. On average, equities analysts predict that Surgery Partners Inc. will post $0.54 earnings per share for the current year.

Several institutional investors have recently added to or reduced their stakes in the stock. Jennison Associates LLC purchased a new position in Surgery Partners during the fourth quarter worth approximately $34,117,000. Wells Fargo & Company MN purchased a new position in Surgery Partners during the fourth quarter worth approximately $14,025,000. Sei Investments Co. purchased a new position in Surgery Partners during the fourth quarter worth approximately $3,201,000. Finally, Oxford Asset Management purchased a new position in Surgery Partners during the fourth quarter worth approximately $3,178,000.

Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.